All pregnant women deserve the right to reliable prenatal testing. But until now, screening for trisomies has been limited by the complexity, cost and capacity of existing NIPT technologies.
Now, due to a breakthrough in advanced genetic analytics, we are developing a solution designed to make it simpler for any laboratory to provide high-precision NIPT with a fully automated platform. more
Vanadis™ NIPT will be the first non-invasive prenatal testing platform designed to simplify screening for trisomies 21, 18 and 13 by eliminating the need for complex DNA amplification and analysis. The result will be a complete NIPT platform that any diagnostic lab can install, operate and connect with their existing LIMS system. more